D57.451 Sickle-cell thalassemia beta plus with acute chest syndrome

✓ Billable ICD-10-CM 2026
Open D57.451 in Web App →

The ICD-10-CM code for Sickle-cell thalassemia beta plus with acute chest syndrome is D57.451 (FY2026). It is a billable, claim-ready diagnosis code.

Classification

Section
D55-D59: Hemolytic anemias (D55-D59)
Category D57
53 codes (43 billable)
FY2026 Status
Stable since FY2024

Also Known As

ICD-10-CM Alphabetic Index entries that lead to D57.451:

  • Disease, diseased › hemoglobin or Hb › S or SS › beta plus › with › acute chest syndrome
  • Disease, diseased › sickle-cell › thalassemia › beta plus › with › acute chest syndrome

Inclusion Terms

  • HbS-beta plus with acute chest syndrome
  • Sickle-cell beta plus with acute chest syndrome

U.S. Hospital Utilization

  • An estimated 205 U.S. inpatient stays in 2023 included D57.451 among the documented diagnoses.
  • 160 stays listed it as the principal diagnosis.

Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.

Official Coding Guidelines

Chapter 3 TOC entry

3. Chapter 3: Disease of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89) ............................................................................................. 39

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.3
Reserved for future guideline expansion

Reserved for future guideline expansion ...................................................................................... 39

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.3.Reserved

Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026

References

Related Codes

Search all 70,000+ ICD-10-CM codes →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2025-10-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial